InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Lenz Robert A.. Insider active across 2 companies, notably Neumora Therapeutics, Inc.. In total, 7 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €752k. History available since 14 September 2023. The latest transaction was filed on 18 February 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Lenz Robert A. is Head of R&D at Neumora Therapeutics, Inc. (XNAS). He has 6 filings in total, and across the recent filings observed from 2023-09-18 to 2025-02-20, they are sales totaling EUR 752282.